Recombinant Human COCH Protein，GST

Cochlin (COCH) is a widely studied extracellular matrix protein known for its role in the development and maintenance of the inner ear and various connective tissues. Research has increasingly focused on COCH due to its implication in several auditory disorders, including non-syndromic hearing loss. Mutations in the COCH gene have been linked to these conditions, highlighting its significance in auditory function and integrity. The protein exhibits a unique structure that allows it to interact with other extracellular matrix components, influencing cellular behavior, tissue organization, and possibly inflammatory responses. Additionally, COCH's involvement in processes such as tissue repair and regeneration makes it a candidate for therapeutic approaches targeting hearing loss and other related conditions. Investigating the recombinant expression of COCH protein is essential to elucidate its biological functions, explore its potential as a biomarker for auditory diseases, and assess its viability as a therapeutic target. Through the production of recombinant COCH, researchers aim to study its biochemical properties, assess its interactions with other molecules, and investigate its role in cellular signaling pathways associated with hearing mechanisms. Understanding the complexities of COCH can pave the way for developing innovative strategies for diagnosing and treating hearing loss and other disorders linked to extracellular matrix dysfunction. As such, tailored recombinant COCH proteins could also serve as tools in the regenerative medicine field, potentially offering insights into novel therapeutic options for auditory and connective tissue-related diseases.